Hua Medicine says its new drug application (NDA) for HuaTangNing (dorzagliatin tablets) has been approved by the National Medical Products Administration (NMPA) in China. HuaTangNing is a first-in-class glucokinase activator (GKA) developed by the company. The approval is for two indications, both to improve blood glucose control for type 2 diabetes (T2D) patients, as monotherapy […]

GATC Health says the new drug candidates discovered by its proprietary AI drug discovery and prediction platform to treat opioid use disorder (OUD) and fentanyl addiction have entered pre-clinical development.  GATC is partnering with Christie D. Fowler at the University of California, Irvine (UCI) and global scientific testing company, Eurofins Discovery, for the pre-clinical programs […]

Addiction Cure Therapeutic Sciences Inc., a biotech company targeting drug and alcohol addiction cures and treatments, has announced results from its epigenetic testing. Data from the mouse models in-lab testing indicates a lead HDAC (histone deacetylases) inhibitor can modulate the behavioral effects of methamphetamine, promoting sustained protection, despite repeated exposure to methamphetamine. If successful, this […]